Ontology highlight
ABSTRACT:
SUBMITTER: Eikelboom JW
PROVIDER: S-EPMC5295520 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature
Eikelboom John W JW Connolly Stuart J SJ
Cardiology research 20150611 3
The new generation of non-vitamin K antagonist oral anticoagulants (NOACs) have been welcomed as a convenient alternative to warfarin. Three new oral anticoagulants, dabigatran etexilate, rivaroxaban and apixaban have been approved for the prevention of stroke and systemic embolism (SSE) in patients with atrial fibrillation (AF) and the prevention of venous thromboembolic events (VTEs) in patients who have undergone elective hip or knee replacement surgery. Dabigatran etexilate and rivaroxaban a ...[more]